Cognition Disorder Clinical Trials

6 recruiting

Cognition Disorder Trials at a Glance

20 actively recruiting trials for cognition disorder are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Gentofte Municipality, Boston, and Cairo. Lead sponsors running cognition disorder studies include Professor Klaus Bønnelykke, University Hospital, Basel, Switzerland, and Consorci Sanitari de l'Alt Penedès i Garraf.

Browse cognition disorder trials by phase

Treatments under study

About Cognition Disorder Clinical Trials

Looking for clinical trials for Cognition Disorder? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cognition Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cognition Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Not Applicable

Brain Stimulation and Cognitive Training for MCI

Mild Neurocognitive DisorderCognitive DysfunctionMild Cognitive Impairment (MCI)+2 more
Medical University of South Carolina50 enrolled1 locationNCT07526740
Recruiting
Not Applicable

Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults

Cognition Disorders
Yuju Wu964 enrolled1 locationNCT06836440
Recruiting

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

Depression - Major Depressive DisorderCognition Disorders in Old Age
Aziende Chimiche Riunite Angelini Francesco S.p.A120 enrolled1 locationNCT07377682
Recruiting
Phase 2

Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients

Cognition Disorders in Old AgeCognitive and Behavioral Impairment
German University in Cairo60 enrolled1 locationNCT07338682
Recruiting
Not Applicable

Nutrition-based Interventions to Prevent Cognitive Decline

Cognitive ImpairmentCognitive DysfunctionMemory Disorders+2 more
Instituto de Saude Publica da Universidade do Porto120 enrolled2 locationsNCT06853405
Recruiting
Phase 4

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

ConfusionCognitive DysfunctionMolecular Mechanisms of Pharmacological Action+14 more
Sunnybrook Health Sciences Centre2,400 enrolled8 locationsNCT04289142
Recruiting
Phase 3

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06570889
Recruiting
Phase 3

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06560255
Recruiting
Not Applicable

LSVT Big and Dual Task Training in Cognitive Impaired Patients

Cognitive ImpairmentCognition Disorders in Old AgeBalance Changes+1 more
Riphah International University50 enrolled1 locationNCT06927362
Recruiting
Not Applicable

Interventions in Mathematics and Cognitive Skills

Cognitive ChangeCognitive DysfunctionDecision Making+25 more
Stanford University180 enrolled1 locationNCT05201534
Recruiting

Neuropsychological Assessment Of The Oldest-Old Population.(NEUROPSIC-GR)

DementiaCognition Disorders in Old Age
Consorci Sanitari de l'Alt Penedès i Garraf120 enrolled6 locationsNCT05481749
Recruiting
Not Applicable

VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical

Brain DiseasesStrokeCerebrovascular Disorders+2 more
University Hospital, Grenoble40 enrolled1 locationNCT04911738
Recruiting

Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool

Cognitive ImpairmentCognitive DeclinePostoperative Delirium+3 more
University Hospital, Basel, Switzerland475 enrolled1 locationNCT03360838
Recruiting
Early Phase 1

Probiotics in Mild Alzheimer's Disease

Neurodegenerative DiseasesCognition Disorders in Old Age
University of Nicosia40 enrolled1 locationNCT06181513
Recruiting

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

DementiaCognitive DeclineAlzheimer Disease+3 more
Alzheimer's Light LLC2,000 enrolled1 locationNCT03657745
Recruiting
Not Applicable

Brain Health Virtual Reality Study

Cognitive ChangeCognitive DeclineMemory Disorders+8 more
University of California, San Diego150 enrolled1 locationNCT06124339
Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Dementia AlzheimersMild Cognitive ImpairmentNeurocognitive Disorders+1 more
University Hospital, Basel, Switzerland100 enrolled1 locationNCT03672279
Recruiting

Human Epilepsy Genetics--Neuronal Migration Disorders Study

EpilepsyCognition DisorderBrain Malformation+1 more
Harvard University Faculty of Medicine3,500 enrolled1 locationNCT00041600
Recruiting
Not Applicable

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Cognitive ImpairmentBrain DiseasesCentral Nervous System Diseases+7 more
Zhejiang University1,200 enrolled1 locationNCT05886114
Recruiting
Phase 2

The effect of Memantine on cognition disorders induced by Electroconvulsive therapy (ECT)

Post ECT cognition disorders
Mohammad Abbasinazari40 enrolled1 locationACTRN12614000619640